Amundi expands gold ETC offerings with new tranche

LONDON - Amundi Physical Metals plc has announced the issuance of a new tranche for its Amundi Physical Gold ETC, under the Secured Precious Metal Linked ETC Securities Programme. The latest tranche, Tranche 674, involves the issue of 94,500 ETC Securities, adding to the already existing 57,300,059 ETC Securities immediately following the new issue.

Scheduled for 31 March 2025, this issue continues to offer investors an alternative means of gaining exposure to gold prices, akin to a direct investment in the physical metal, without the need for physical delivery. The ETC Securities, linked to the price of gold, are designed to provide purchasers with exposure to the commodity, with each ETC Security relating to a specific weight in gold, known as the Metal Entitlement.

The ETC Securities are secured obligations of the issuer, with the obligations under the ETC Securities backed by gold held by HSBC Bank plc as the custodian. The Metal Entitlement for each ETC Security is subject to a Total (EPA:TTEF) Expense Ratio (TER) of 0.12% per annum, which funds the operational fee of Amundi Physical Metals plc. The TER is designed to cover all ongoing costs associated with managing and operating the ETC structure.

Investors should note that the ETC Securities are not the exact equivalent of an investment in gold but provide a level of participation in the gold market through the securities market. The ETC Securities will be listed and admitted to trading on several European exchanges, including Euronext (EPA:ENX) Paris, Euronext Amsterdam, Deutsche Börse, Borsa Italiana, and the London Stock Exchange (LON:LSEG).

Amundi’s offering aims to cater to the growing investor appetite for precious metals as a hedge against inflation and currency fluctuations. The issuer has emphasized the importance of providing a cost-effective and transparent way for investors to add gold to their portfolios.

This information is based on a press release statement, and potential investors are advised to read the Base Prospectus, including any supplements, and the Final Terms before making any investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.